Assessment and Treatment of Adolescent Hair Loss

    June 2026 in “ Current Opinion in Pediatrics ”
    Adrienne Conza, Nujood Alzahrani, Yasin Damji
    Studysummary This study emphasized that trichoscopy and ultraviolet-enhanced follicular dermoscopy enhance diagnostic accuracy in adolescent alopecia, while systemic JAK inhibitors offer promising treatment options, reflecting the need for specialized, etiology-driven approaches and highlighting knowledge gaps in prevention and long-term outcomes.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on journals.lww.com →
    Discuss this study in the Community →

    Research cited in this study 27

    1. Insights In Trichoscopy: The Utility Of Ultraviolet-Induced Fluorescence Dermoscopy In Diagnosis Of Alopecia Areata And Tinea Capitis In The Pediatric Population Pediatric Dermatology · 2025
    2. Upadacitinib Therapy in Adolescent Severe Alopecia Areata: A Case Series and Narrative Review Clinical Cosmetic and Investigational Dermatology · 2025
    3. Alopecia in Children with Cancer: A Review from Pathophysiology to Management American Journal of Clinical Dermatology · 2025
    4. Tumor Necrosis Factor α Inhibitor-Induced Alopecia in Pediatric Patients: A Cohort of 20 Patients and Review of the Literature Archives of Dermatological Research · 2025
    5. Correlation Between Increased Total Serum IgE Levels and Clinical Features in Alopecia Areata Patients Frontiers in Immunology · 2025
    6. Hair Loss in Teenagers: A Review for Primary Care Pediatricians Pediatric Annals · 2025
    7. Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review Journal of Clinical Medicine · 2025
    8. Friend Or Foe: A Systematic Review Of Dupilumab And Alopecia Areata Journal of the American Academy of Dermatology · 2025
    9. Understanding Eyebrow and Eyelash Involvement in Patients with Alopecia Areata and Responsiveness to Treatment with Baricitinib PubMed · 2025
    10. Comprehensive Evaluation of Androgenetic Alopecia: Demographic Characteristics, Psychosocial Impact, and the Role of Social Media in Treatment Choices Journal of Cosmetic Dermatology · 2025
    11. Pathophysiology of Alopecia Areata in the Pediatric Patient Pediatric Dermatology · 2025
    12. Assessment of Alopecia Areata Disease Severity in Pediatric Patients Pediatric Dermatology · 2025
    13. Clinical Presentations and Comorbidities of Pediatric Alopecia Areata Pediatric Dermatology · 2025
    14. Patterns of Clinical Response in Patients With Alopecia Areata Treated With Ritlecitinib in the Allegro Clinical Development Programme Journal of the European Academy of Dermatology and Venereology · 2025
    15. Oral Tofacitinib for the Management of Moderate to Severe Alopecia Areata in Children and Adolescents: A Retrospective Study of 36 Patients Pediatric Dermatology · 2025
    16. An International Multicenter Retrospective Cohort Study of 203 Patients with Pediatric Androgenetic Alopecia Journal of the American Academy of Dermatology · 2025
    17. Long-Term Safety and Efficacy of Ritlecitinib in Adults and Adolescents with Alopecia Areata and at Least 25% Scalp Hair Loss: Results from the ALLEGRO-LT Phase 3, Open-Label Study Journal of the European Academy of Dermatology and Venereology · 2025
    18. Frequency of Types of Alopecia in a Single-Center Hair Referral Clinic Over a Ten-Year Period International Journal of Trichology · 2025
    19. Wood's Lamp for Early Detection of Microsporum Canis Tinea Capitis in Children Photodiagnosis and Photodynamic Therapy · 2024
    20. Clinical, Laboratory, and Trichoscopic Features of Pediatric Androgenetic Alopecia Cutis · 2024
    21. Low-Dose Oral Minoxidil Initiation for Patients With Hair Loss JAMA Dermatology · 2024
    22. Trichoscopic Evaluation of Focal Non-Cicatricial Alopecia in Egyptian Children Dermatology Practical & Conceptual · 2024
    23. Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The Allegro Phase 2b/3 Randomized Clinical Trial American Journal of Clinical Dermatology · 2024
    24. Efficacy and Safety of the Oral Janus Kinase 3/Tyrosine Kinase Inhibitor Ritlecitinib Over 24 Months: Integrated Analysis of the ALLEGRO Phase IIb/III and Long-Term Phase III Clinical Studies in Alopecia Areata British Journal of Dermatology · 2024
    25. Psychosocial Impact of Alopecia Areata in Pediatric and Adolescent Populations: A Systematic Review Journal of Paediatrics and Child Health · 2024
    26. The Alopecia Areata Severity And Morbidity Index (ASAMI) Study JAMA Dermatology · 2024
    27. Telogen Effluvium: A Review of the Science and Current Obstacles Journal of Dermatological Science · 2021